Genmab — Juli 2018
-
Expert Discusses Daratumumab Developments in Myeloma https://www.onclive.com/web-exclusives/expert-discusses-daratumumab-developments-in-myeloma
-
they started recruiting in november https://www.clinicaltrials.gov/ct2/show/NCT03277105?term=daratumumab+subcutaneous&rank=4
-
-
Absolut - men det er dælme lang tid siden, vi har set noget fornuftigt fra den kant. Det viker som om, GEN's egne teknologier ikker er nok til at trække en større deal - hvorimod programmer med partnere som TF eller AXL eller immunologiprogrammerne vækker større interesse hos big pharma. Tænker du, at GEN stadig har umpf nok i sine egne programmer til at lave noget fornuftig på deal-fronten?
-
https://finance.yahoo.com/quote/MBVX?p=MBVX
Pæn stigning
-
På Clinical Trials er dette studie med JNJ-63723283 blevet opdateret 9/7 (Submitted by sponsor 5/7). Study start er ændret fra 3/7 til 17/8 2018!https://clinicaltrials.gov/ct2/show/NCT03547037?term=63723283&rank=2
-
-
God morgen

-
God morgen

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind